Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?Rosalie A. Scholtes, Daniël H. van Raalte, Max Nieuwdorp et al.|Diabetes Obesity and Metabolism|2019Cited by 35
Author response for "Sodium glucose cotransporter (SGLT)-2 inhibitors: do we need them for glucose-lowering, for cardiorenal protection or both?"Rosalie A. Scholtes, Daniël H. van Raalte, Michaël J.B. van Baar et al.|Unknown|2019Cited by 0